Registration Deadline:
Event Contact:
Explore other Industry Opportunities:
Bayer Pharmaceuticals’ Medical Education department is committed to funding independent medical education initiatives that help to address important healthcare professional educational gaps and improve patient care. Expected Monetary Range: Up to $350,000
Therapeutic Area:
Activating HER2mut Alterations as Actionable Biomarkers in NSCLC
- HER2 in NSCLC: Understanding Alterations and Testing
- Tissue and ctDNA “liquid biopsy”
- Interpreting biomarker testing results encompassing HER2-activating mutations
- Evolving Treatment Options for NSCLC with HER2-activating mutations
- Differences between evolving treatment options for NSCLC with HER2-activating mutations
- Personalizing care plans for patients with NSCLC and HER2-activating mutations
- Optimizing patient experience
- Empowering Patients Receiving Treatment for HER2-mutated NSCLC
- Practical solutions to facilitate communication between patients and the care team
- Help patients and HCPs navigate barriers to care continuity
How to Submit:
- Review Bayer Pharmaceuticals Grant Guidelines
- Review additional CGA requirements outlined within this document.
- Submit via Bayer Pharmaceuticals’ online request form: Link
Please note: Faculty and researchers interested in applying for these opportunities based on technologies developed or disclosed at Vanderbilt must submit their proposals through the CTTC.